Portfolio company
Biomodal
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops multiomics sequencing kits and software for life scientists and clinical developers to analyse genetic and epigenetic data from single DNA samples.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioSkryb
This company develops genomic amplification and sequencing systems for researchers and clinicians to analyse DNA and RNA from single cells.
ArgenTAG
This company develops single-cell genomic sequencing kits and barcoding technology for researchers to analyse complex biological data using long-read sequencing platforms.
Epigenica
This company develops epigenetic analysis kits and screening tools for researchers in drug discovery, diagnostics, and precision medicine.
Tagomics
This biotechnology company develops a multiomic profiling platform to assist biopharma and diagnostic organisations with disease detection, drug development and therapy selection.
Wobble Genomics
This company develops full-length RNA sequencing technology for pharmaceutical and diagnostic organisations to improve biomarker discovery, patient stratification and clinical success rates.
Cellanome
This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.
BioBox Analytics
BioBox Analytics provides a cloud-based data analytics platform for scientists and biopharma companies to process, analyse and explore genomic and multi-modal sequencing data.
VUGENE
This company provides a software platform for multi-omics data analysis and interpretation to academic researchers and biotechnology organisations.
